ACH’s statement was included in Bloomberg Law’s article today on HRSA’s letter to J&J on their proposed 340 drug rebate program: HRSA wrote it expects J&J to cease implementation immediately and to inform the agency no later than Sept. 30 in order to provide adequate notice to covered entities. Hospital groups including 340B Health and Advocates […]
Advocates for Community Health (ACH) applauds the Health Resources and Services Administration (HRSA)’s strong and clear statement today that a rebate model is not consistent with the 340B Drug Discount Pricing Program, and that they will take enforcement action against companies that pursue one. The rebate model is especially challenging for community health centers, and we are […]
U.S. Senator Peter Welch (D-Vt.) yesterday introduced the bicameral 340B Pharmaceutical Access To Invest in Essential, Needed Treatments & Support (PATIENTS) Act, legislation that would protect the 340B drug pricing program and ensure patients—especially those in lower income and rural communities—can continue care with providers who utilize the program. ACH provided the following statement in support […]
“One group desperately hoping Congress acts is community health centers, who were some of the original intended beneficiaries of 340B,” writes Michael McAuliff at Modern Healthcare. “Advocates had hoped to see a final draft of the SUSTAIN Act ahead of National Health Center Week in Washington this week. ‘The program has begun to narrow over […]
Advocates for Community Health (ACH) is tirelessly advocating and urging federal policymakers to ensure that America’s largest network of primary care providers can continue caring for more than 31 million patients annually in underserved communities. This will require proper funding and resources to position community health centers (CHCs) at the core of the healthcare system. […]
Advocates for Community Health (ACH)—a member-led organization for federally qualified health centers (FQHCs) with a mission to meaningfully impact federal policy—is working with UnitedHealthcare Community & State to address these challenges and harness the insights, vision and innovation of ACHs members and leadership. Together, we are launching a three-year plan to empower FQHC leaders to drive change in their communities.
WASHINGTON, D.C. — On behalf of our members – community health centers that are leading the nation in innovation and ingenuity in primary and preventive care – Advocates for Community Health (ACH) applauds the bipartisan U.S. Senate 340B Working Group’s efforts on the legislative draft intended to improve the 340B Drug Discount Program. It is […]
Advocates for Community Health (ACH)—a member-led organization for federally qualified health centers (FQHCs) with a mission to meaningfully impact federal policy—is working with UnitedHealthcare Community & State to address these challenges and harness the insights, vision and innovation of ACHs members and leadership. Together, we are launching a three-year plan to empower FQHC leaders to drive change in their communities.
Advocates for Community Health (ACH)—a member-led organization for federally qualified health centers (FQHCs) with a mission to meaningfully impact federal policy—is working with UnitedHealthcare Community & State to address these challenges and harness the insights, vision and innovation of ACHs members and leadership. Together, we are launching a three-year plan to empower FQHC leaders to drive change in their communities.
The 340B program has long faced scrutiny, yet over the years, Congressional hearing after hearing has verified the record of health centers in leveraging the program appropriately – putting resources back into the communities they are serving. And just last week, another piece of bad news – HRSA’s Administrative Dispute Resolution panel dismissed a complaint on a technicality.